Key Players in the Global Sleep Apnea Devices market are Fisher and Paykel Healthcare, CareFusion Corporation, Natus Medical Incorporated, DeVilbiss Healthcare, Weinmann Medical Devices.
(PRWEB) January 21, 2015
The Global Sleep Apnea Devices market report defines and segments the concerned market globally with analysis and forecast of revenue. The global sleep apnea devices market is expected to reach $20.13 Billion by 2018, and is estimated to grow at a CAGR of 13.4%, from 2013 to 2018.
Browse through the TOC of Global Sleep Apnea Devices Market for an analysis of industry trends, segments & forecasts.
Sleep apnea is a sleep disorder characterized by abnormal pauses in breathing or instances of abnormally low breathing during sleep. There are three basic forms of sleep apnea, namely Central Sleep Apnea (CSA), Obstructive Sleep Apnea (OSA) and Complex/Mixed sleep apnea, constituting 0.4%, 84%, and 15% of the total cases, respectively.
The penetration level of sleep apnea diagnosis as well as therapy remains low across the globe, due to lack of adequate awareness among both patients and physicians. However, due to the association of co-morbidities such as drug-resistant hypertension, congestive heart failure, type 2 diabetes, and stroke with sleep apnea, awareness about the disease is gradually increasing.
Early buyers will receive 10% customization on this report.
The global sleep apnea devices market is mainly driven by colossal pool of sleep apnea patients, increasing awareness, growing use of oral appliances, and technological advancement. The market is dominated by North America, followed by Europe, Asia. North America will continue to lead the sleep apnea devices market in the years to come, followed by Europe. As reimbursement policies have become more consistent across European countries, sustained steady growth is expected.
Speak to Analyst @
The Asian region’s contribution to the global sleep apnea devices market is expected to pick up in the coming years, as the medical condition is now recognized, both by patients and the medical fraternity.Moreover, growth in the Asian market is likely to be propelled by a large untapped patient base, gradual increasing awareness, rising affluence, growth in the number of sleep labs in sleep centers and hospitals, and influx of well-established players.
The global sleep apnea devices market is segmented by type, categorized as sleep apnea diagnostics devices and sleep apnea therapeutic devices. On the basis of geography, the report analyzes major regionsand the countries such as the North America, Europe, Asia, and ROW.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market, including major companies of the market.
North America Sleep Apnea Diagnostic Devices Market
The North American Sleep Apnea Diagnostic Devices Market, mainly driven by enormous patient base of Obstructive Sleep Apnea (OSA) accompanied by technological amelioration of well designed PSG devices, Pulse Oximeters, Two Channel Screening Devices, was valued at $2.1 billion in 2013 and is expected to reach $4.2 billion by 2018, at a CAGR of 14.9%. The Polysomnography (PSG) market constitutes the largest segment of the North American market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.